Literature DB >> 11119584

Gps2, a protein partner for human papillomavirus E6 proteins.

Y Y Degenhardt1, S J Silverstein.   

Abstract

We have used the yeast two-hybrid system to screen a cDNA library prepared from normal human epidermal keratinocytes and identified protein partners for human papilloma virus (HPV) E6 proteins. A clone that encoded Gps2 interacted with E6 proteins from HPVs of high and low oncogenic risk. The specificity of these reactions was verified and the regions of E6 that were required for interaction were mapped. Steady-state and pulse-chase analyses of cells cotransfected with DNAs expressing E6 from either HPV6 or HPV18 and Gps2 demonstrated that the E6 proteins induced the degradation of Gps2 in vivo but not in vitro. Gps2 exhibited transcriptional activation activity, and high-risk E6 suppressed this activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11119584      PMCID: PMC113908          DOI: 10.1128/JVI.75.1.151-160.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  81 in total

1.  Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma.

Authors:  C D Woodworth; J Doniger; J A DiPaolo
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

2.  Human papillomavirus type 16 DNA-induced malignant transformation of NIH 3T3 cells.

Authors:  S Yasumoto; A L Burkhardt; J Doniger; J A DiPaolo
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

3.  Intracellular localization and DNA-binding properties of human papillomavirus type 18 E6 protein expressed with a baculovirus vector.

Authors:  S R Grossman; R Mora; L A Laimins
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

4.  Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation.

Authors:  D Gardiol; C Kühne; B Glaunsinger; S S Lee; R Javier; L Banks
Journal:  Oncogene       Date:  1999-09-30       Impact factor: 9.867

5.  Identification of a second transforming region in bovine papillomavirus DNA.

Authors:  J T Schiller; W C Vass; D R Lowy
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

6.  Characterization of primary human keratinocytes transformed by human papillomavirus type 18.

Authors:  P Kaur; J K McDougall
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

7.  Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA.

Authors:  L Pirisi; S Yasumoto; M Feller; J Doniger; J A DiPaolo
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

8.  Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells.

Authors:  G Matlashewski; J Schneider; L Banks; N Jones; A Murray; L Crawford
Journal:  EMBO J       Date:  1987-06       Impact factor: 11.598

9.  Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines.

Authors:  E J Androphy; N L Hubbert; J T Schiller; D R Lowy
Journal:  EMBO J       Date:  1987-04       Impact factor: 11.598

10.  Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma.

Authors:  R Schlegel; W C Phelps; Y L Zhang; M Barbosa
Journal:  EMBO J       Date:  1988-10       Impact factor: 11.598

View more
  24 in total

1.  The E6 protein of the cutaneous human papillomavirus type 8 can stimulate the viral early and late promoters by distinct mechanisms.

Authors:  Andreas Müller-Schiffmann; Julia Beckmann; Gertrud Steger
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31.

Authors:  Choongho Lee; Laimonis A Laimins
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

Review 3.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

4.  Interaction of zyxin, a focal adhesion protein, with the e6 protein from human papillomavirus type 6 results in its nuclear translocation.

Authors:  Y Y Degenhardt; S Silverstein
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  A mutant of human papillomavirus type 16 E6 deficient in binding alpha-helix partners displays reduced oncogenic potential in vivo.

Authors:  Marie Nguyen; Shiyu Song; Amy Liem; Elliot Androphy; Yun Liu; Paul F Lambert
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

6.  PATJ, a tight junction-associated PDZ protein, is a novel degradation target of high-risk human papillomavirus E6 and the alternatively spliced isoform 18 E6.

Authors:  Carina H Storrs; Saul J Silverstein
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

7.  Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3.

Authors:  Ajay Kumar; Yongtong Zhao; Gaoyuan Meng; Musheng Zeng; Seetha Srinivasan; Laurie M Delmolino; Qingshen Gao; Goberdhan Dimri; Georg F Weber; David E Wazer; Hamid Band; Vimla Band
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

Review 8.  Papillomavirus E6 proteins.

Authors:  Heather L Howie; Rachel A Katzenellenbogen; Denise A Galloway
Journal:  Virology       Date:  2008-12-10       Impact factor: 3.616

9.  G-protein pathway suppressor 2 (GPS2) interacts with the regulatory factor X4 variant 3 (RFX4_v3) and functions as a transcriptional co-activator.

Authors:  Donghui Zhang; G Jean Harry; Perry J Blackshear; Darryl C Zeldin
Journal:  J Biol Chem       Date:  2008-01-24       Impact factor: 5.157

10.  Biomarkers in cervical cancer.

Authors:  Eun-Kyoung Yim; Jong-Sup Park
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.